Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status

AIDS. 2001 Nov 23;15(17):2267-75. doi: 10.1097/00002030-200111230-00008.

Abstract

Objective: To evaluate long-term immune reconstitution of children treated with highly active antiretroviral therapy (HAART).

Methods: The long-term immunological response to HAART was studied in 71 HIV-1-infected children (aged 1 month to 18 years) in two prospective, open, uncontrolled national multicentre studies. Blood samples were taken before and after HAART was initiated, with a follow-up of 96 weeks, and peripheral CD4 and CD8 T cells plus naive and memory subsets were identified in whole blood samples. Relative cell counts were calculated in relation to the median of the age-specific reference.

Results: The absolute CD4 cell count and percentage and the CD4 cell count as a percentage of normal increased significantly (P < 0.001) to medians of 939 x 106 cells/l (range, 10-3520), 32% (range, 1-50) and 84% (range, 1-161), respectively, after 48 weeks. This increase was predominantly owing to naive CD4 T cells. There was a correlation between the increase of absolute naive CD4 T cell counts and age. However, when CD4 T cell restoration was studied as percentage of normal values, the inverse correlation between the increase of naive CD4 T cell count and age was not observed. In addition, no difference in immunological reconstitution was observed at any time point between virological responders and non-responders.

Conclusions: Normalization of the CD4 cell counts in children treated with HAART is independent of age, indicating that children of all age groups can meet their CD4 T cell production demands. In general, it appears that children restore their CD4 T cell counts better and more rapidly than adults, even in a late stage of HIV-1 infection.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Antibodies, Monoclonal / immunology
  • Antiretroviral Therapy, Highly Active*
  • CD28 Antigens / immunology
  • CD3 Complex / immunology
  • CD4 Lymphocyte Count
  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / drug effects
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • HIV Infections / blood
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Immunologic Memory
  • Infant
  • Prospective Studies
  • RNA, Viral / blood
  • Viral Load

Substances

  • Antibodies, Monoclonal
  • CD28 Antigens
  • CD3 Complex
  • RNA, Viral